FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease Jan. 17, 2020 No Comments
FDA approves Ayvakit for unresectable or metastatic PDGFRA exon 18 mutant GIST Jan. 10, 2020 No Comments
FDA approves Lynparza as first-line maintenance treatment for gBRCAm metastatic pancreatic cancer Dec. 30, 2019 No Comments
RSS